Skip to Main Content

Paper Details

DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia.
Prostate Int
3
2023
BPH, DNA methylation, Genomic DNA, PCa, Twist, advanced PCa, benign prostatic hyperplasia, cancer, chromatin, differentially methylated CpG sites, early-stage, genic loci, patient, patients, prostate cancer, prostate-specific antigen, single CpG site, target
Author NameAffiliation
Woong-Yang ParkGENINUS Inc.
Woong-Yang ParkSungkyunkwan University School of Medicine
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center
Woong-Yang ParkGENINUS Inc.
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center
Woong-Yang ParkSungkyunkwan University School of Medicine
Ji Youl LeeCancer Research Institute, College of Medicine, The Catholic University of Korea
Ji Youl LeeSeoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea
  • 1 - 8

Datasets

Dataset
Description
Source Link
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Gene OntologyGene Ontology DatabaseLink
Release 1.2